Last 12 months
Inside the activity.
1 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 13 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2025 Filed Aug 1, 2025 22:31 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,900 | $0.00 Strike: $65.45 | $0.00 |
DisclosureSEC source: 0000740260-25-000234 · wk-form4_1754087473.xml · derivative · entry 3 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,282 Underlying: Common Stock · 3,900 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. F4 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| July 31, 2025 Filed Aug 1, 2025 22:31 UTC |
Probst Robert FEVP and CFO
|
SaleCommon Stock | 3,900 | $68.45 | $266,960.07 |
DisclosureSEC source: 0000740260-25-000234 · wk-form4_1754087473.xml · nonDerivative · entry 2 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,364 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $68.45 to $68.47, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 31, 2025 Filed Aug 1, 2025 22:31 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionCommon Stock | 3,900 | $65.45 | $255,255.00 |
DisclosureSEC source: 0000740260-25-000234 · wk-form4_1754087473.xml · nonDerivative · entry 1 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 172,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. Read SEC document |
| July 21, 2025 Filed Jul 23, 2025 20:30 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 29,493 | $0.00 Strike: $63.24 | $0.00 |
DisclosureSEC source: 0000740260-25-000224 · wk-form4_1753302617.xml · derivative · entry 3 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,182 Underlying: Common Stock · 29,493 shares Expires 2026-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. F4 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| July 21, 2025 Filed Jul 23, 2025 20:30 UTC |
Probst Robert FEVP and CFO
|
SaleCommon Stock | 29,493 | $66.29 | $1,954,949.40 |
DisclosureSEC source: 0000740260-25-000224 · wk-form4_1753302617.xml · nonDerivative · entry 2 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,364 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 16 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $66.24 to $66.4236, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 21, 2025 Filed Jul 23, 2025 20:30 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionCommon Stock | 29,493 | $63.24 | $1,865,137.32 |
DisclosureSEC source: 0000740260-25-000224 · wk-form4_1753302617.xml · nonDerivative · entry 1 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 197,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 16 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. Read SEC document |
| July 18, 2025 Filed Jul 18, 2025 23:04 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,098 | $0.00 Strike: $63.24 | $0.00 |
DisclosureSEC source: 0000740260-25-000218 · wk-form4_1752879845.xml · derivative · entry 3 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,675 Underlying: Common Stock · 4,098 shares Expires 2026-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. F4 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| July 18, 2025 Filed Jul 18, 2025 23:04 UTC |
Probst Robert FEVP and CFO
|
SaleCommon Stock | 4,098 | $66.24 | $271,454.39 |
DisclosureSEC source: 0000740260-25-000218 · wk-form4_1752879845.xml · nonDerivative · entry 2 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,364 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 16 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $66.24 to $66.26, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 18, 2025 Filed Jul 18, 2025 23:04 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionCommon Stock | 4,098 | $63.24 | $259,157.52 |
DisclosureSEC source: 0000740260-25-000218 · wk-form4_1752879845.xml · nonDerivative · entry 1 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 172,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 16 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. Read SEC document |
| July 18, 2025 Filed Jul 18, 2025 23:03 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,375 | $0.00 Strike: $65.45 | $0.00 |
DisclosureSEC source: 0000740260-25-000213 · wk-form4_1752879792.xml · derivative · entry 3 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 701,931 Underlying: Common Stock · 4,375 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. F4 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| July 18, 2025 Filed Jul 18, 2025 23:03 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
SaleCommon Stock | 4,375 | $65.82 | $287,976.50 |
DisclosureSEC source: 0000740260-25-000213 · wk-form4_1752879792.xml · nonDerivative · entry 2 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,145,695 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $65.6534 to $66.2339, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 18, 2025 Filed Jul 18, 2025 23:03 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 4,375 | $65.45 | $286,343.75 |
DisclosureSEC source: 0000740260-25-000213 · wk-form4_1752879792.xml · nonDerivative · entry 1 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,150,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. Read SEC document |
| July 17, 2025 Filed Jul 18, 2025 23:04 UTC |
Smith Maurice SDirector
|
GrantCommon Stock | 78.961 | $65.37 | $5,161.68 |
DisclosureSEC source: 0000740260-25-000220 · wk-form4_1752879863.xml · nonDerivative · entry 2 Smith Maurice S · CIK 0001841752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,814.351 F3 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on July 17, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 17, 2025 Filed Jul 18, 2025 23:04 UTC |
Smith Maurice SDirector
|
GrantCommon Stock | 58.478 | $65.37 | $3,822.71 |
DisclosureSEC source: 0000740260-25-000220 · wk-form4_1752879863.xml · nonDerivative · entry 1 Smith Maurice S · CIK 0001841752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,735.39 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on July 17, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 17, 2025 Filed Jul 18, 2025 23:04 UTC |
Rodriguez Joe Vasquez Jr.Director
|
GrantCommon Stock | 48.767 | $65.37 | $3,187.90 |
DisclosureSEC source: 0000740260-25-000219 · wk-form4_1752879854.xml · nonDerivative · entry 1 Rodriguez Joe Vasquez Jr. · CIK 0002014328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,718.288 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on July 17, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 17, 2025 Filed Jul 18, 2025 23:04 UTC |
NADER MARGUERITE MDirector
|
GrantCommon Stock | 78.961 | $65.37 | $5,161.68 |
DisclosureSEC source: 0000740260-25-000217 · wk-form4_1752879837.xml · nonDerivative · entry 1 NADER MARGUERITE M · CIK 0001356681 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,215.393 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on July 17, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 17, 2025 Filed Jul 18, 2025 23:03 UTC |
Martino Roxanne MDirector
|
GrantCommon Stock | 206.58 | $65.37 | $13,504.13 |
DisclosureSEC source: 0000740260-25-000216 · wk-form4_1752879824.xml · nonDerivative · entry 1 Martino Roxanne M · CIK 0001676558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,486.851 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on July 17, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 17, 2025 Filed Jul 18, 2025 23:03 UTC |
LUSTIG MATTHEW JDirector
|
GrantCommon Stock | 78.961 | $65.37 | $5,161.68 |
DisclosureSEC source: 0000740260-25-000215 · wk-form4_1752879815.xml · nonDerivative · entry 2 LUSTIG MATTHEW J · CIK 0001203367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,759.272 F3 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on July 17, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 17, 2025 Filed Jul 18, 2025 23:03 UTC |
LUSTIG MATTHEW JDirector
|
GrantCommon Stock | 261.058 | $65.37 | $17,065.36 |
DisclosureSEC source: 0000740260-25-000215 · wk-form4_1752879815.xml · nonDerivative · entry 1 LUSTIG MATTHEW J · CIK 0001203367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,680.311 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on July 17, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 17, 2025 Filed Jul 18, 2025 23:03 UTC |
EMBLER MICHAEL JDirector
|
GrantCommon Stock | 78.961 | $65.37 | $5,161.68 |
DisclosureSEC source: 0000740260-25-000214 · wk-form4_1752879804.xml · nonDerivative · entry 1 EMBLER MICHAEL J · CIK 0001209170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,445.393 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on July 17, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 17, 2025 Filed Jul 18, 2025 23:03 UTC |
Barnes Melody CDirector
|
GrantCommon Stock | 78.961 | $65.37 | $5,161.68 |
DisclosureSEC source: 0000740260-25-000212 · wk-form4_1752879782.xml · nonDerivative · entry 1 Barnes Melody C · CIK 0001619369 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,050.393 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on July 17, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 17, 2025 Filed Jul 21, 2025 22:55 UTC |
Roy SumitDirector
|
GrantCommon Stock | 78.961 | $65.37 | $5,161.68 |
DisclosureSEC source: 0000740260-25-000222 · wk-form4_1753138548.xml · nonDerivative · entry 2 Roy Sumit · CIK 0001529329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,770.297 F3 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on July 17, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 17, 2025 Filed Jul 21, 2025 22:55 UTC |
Roy SumitDirector
|
GrantCommon Stock | 49.07 | $65.37 | $3,207.71 |
DisclosureSEC source: 0000740260-25-000222 · wk-form4_1753138548.xml · nonDerivative · entry 1 Roy Sumit · CIK 0001529329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,691.336 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on July 17, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 16, 2025 Filed Jul 16, 2025 23:43 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,224 | $0.00 Strike: $65.45 | $0.00 |
DisclosureSEC source: 0000740260-25-000200 · wk-form4_1752709393.xml · derivative · entry 9 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 706,306 Underlying: Common Stock · 1,224 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. F6 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| July 16, 2025 Filed Jul 16, 2025 23:43 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
SaleCommon Stock | 1,224 | $65.62 | $80,320.23 |
DisclosureSEC source: 0000740260-25-000200 · wk-form4_1752709393.xml · nonDerivative · entry 6 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,145,695 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F4 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $65.60 to $65.66, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 16, 2025 Filed Jul 16, 2025 23:43 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 1,224 | $65.45 | $80,110.80 |
DisclosureSEC source: 0000740260-25-000200 · wk-form4_1752709393.xml · nonDerivative · entry 5 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,146,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 23:43 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 292 | $0.00 Strike: $65.45 | $0.00 |
DisclosureSEC source: 0000740260-25-000200 · wk-form4_1752709393.xml · derivative · entry 8 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 707,530 Underlying: Common Stock · 292 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. F6 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 23:43 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
SaleCommon Stock | 292 | $65.65 | $19,168.72 |
DisclosureSEC source: 0000740260-25-000200 · wk-form4_1752709393.xml · nonDerivative · entry 4 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,145,695 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F3 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $65.6203 to $65.7461, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 23:43 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 292 | $65.45 | $19,111.40 |
DisclosureSEC source: 0000740260-25-000200 · wk-form4_1752709393.xml · nonDerivative · entry 3 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,145,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. Read SEC document |
| July 14, 2025 Filed Jul 16, 2025 23:43 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 168,318 | $0.00 Strike: $62.22 | $0.00 |
DisclosureSEC source: 0000740260-25-000201 · wk-form4_1752709401.xml · derivative · entry 3 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,773 Underlying: Common Stock · 168,318 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. F4 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| July 14, 2025 Filed Jul 16, 2025 23:43 UTC |
Probst Robert FEVP and CFO
|
SaleCommon Stock | 168,318 | $65.36 | $11,000,742.69 |
DisclosureSEC source: 0000740260-25-000201 · wk-form4_1752709401.xml · nonDerivative · entry 2 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,364 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 19 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $65.22 to $65.67, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 14, 2025 Filed Jul 16, 2025 23:43 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionCommon Stock | 168,318 | $62.22 | $10,472,745.96 |
DisclosureSEC source: 0000740260-25-000201 · wk-form4_1752709401.xml · nonDerivative · entry 1 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 336,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 19 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. Read SEC document |
| July 14, 2025 Filed Jul 16, 2025 23:43 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,753 | $0.00 Strike: $65.45 | $0.00 |
DisclosureSEC source: 0000740260-25-000200 · wk-form4_1752709393.xml · derivative · entry 7 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 707,822 Underlying: Common Stock · 14,753 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. F6 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| July 14, 2025 Filed Jul 16, 2025 23:43 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
SaleCommon Stock | 14,753 | $65.60 | $967,821.88 |
DisclosureSEC source: 0000740260-25-000200 · wk-form4_1752709393.xml · nonDerivative · entry 2 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,145,695 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $65.60 to $65.61, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 14, 2025 Filed Jul 16, 2025 23:43 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 14,753 | $65.45 | $965,583.85 |
DisclosureSEC source: 0000740260-25-000200 · wk-form4_1752709393.xml · nonDerivative · entry 1 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,160,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. Read SEC document |
| July 01, 2025 Filed Jul 1, 2025 22:36 UTC |
Smith Maurice SDirector
|
GrantCommon Stock | 596.469 | $62.87 | $37,500.01 |
DisclosureSEC source: 0000740260-25-000194 · wk-form4_1751409411.xml · nonDerivative · entry 1 Smith Maurice S · CIK 0001841752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,676.912 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 01, 2025 Filed Jul 1, 2025 22:36 UTC |
Roy SumitDirector
|
GrantCommon Stock | 497.057 | $62.87 | $31,249.97 |
DisclosureSEC source: 0000740260-25-000193 · wk-form4_1751409403.xml · nonDerivative · entry 1 Roy Sumit · CIK 0001529329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,642.266 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 01, 2025 Filed Jul 1, 2025 22:36 UTC |
Martino Roxanne MDirector
|
GrantCommon Stock | 846.636 | $62.87 | $53,228.01 |
DisclosureSEC source: 0000740260-25-000192 · wk-form4_1751409393.xml · nonDerivative · entry 1 Martino Roxanne M · CIK 0001676558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,280.271 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| July 01, 2025 Filed Jul 1, 2025 22:36 UTC |
LUSTIG MATTHEW JDirector
|
GrantCommon Stock | 516.94 | $62.87 | $32,500.02 |
DisclosureSEC source: 0000740260-25-000191 · wk-form4_1751409385.xml · nonDerivative · entry 1 LUSTIG MATTHEW J · CIK 0001203367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,419.253 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| May 30, 2025 Filed May 30, 2025 21:24 UTC |
Roberts Carey S.EVP and GC
|
SaleCommon Stock | 23,500 | $64.23 | $1,509,447.30 |
DisclosureSEC source: 0000740260-25-000186 · wk-form4_1748640152.xml · nonDerivative · entry 1 Roberts Carey S. · CIK 0001720831 · EVP and GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,650 F1 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $64.23 to $64.26, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 27, 2025 Filed May 29, 2025 21:05 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,374 | $0.00 Strike: $62.22 | $0.00 |
DisclosureSEC source: 0000740260-25-000183 · wk-form4_1748552711.xml · derivative · entry 3 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,091 Underlying: Common Stock · 17,374 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. F4 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| May 27, 2025 Filed May 29, 2025 21:05 UTC |
Probst Robert FEVP and CFO
|
SaleCommon Stock | 17,374 | $65.22 | $1,133,139.23 |
DisclosureSEC source: 0000740260-25-000183 · wk-form4_1748552711.xml · nonDerivative · entry 2 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,364 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 20 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $65.22 to $65.23, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 27, 2025 Filed May 29, 2025 21:05 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionCommon Stock | 17,374 | $62.22 | $1,081,010.28 |
DisclosureSEC source: 0000740260-25-000183 · wk-form4_1748552711.xml · nonDerivative · entry 1 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 185,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 20 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:00 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 33,592 | $0.00 Strike: $53.79 | $0.00 |
DisclosureSEC source: 0000740260-25-000181 · wk-form4_1748034023.xml · derivative · entry 4 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,465 Underlying: Common Stock · 33,592 shares Expires 2026-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. F6 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:00 UTC |
Probst Robert FEVP and CFO
|
SaleCommon Stock | 33,592 | $64.57 | $2,169,022.00 |
DisclosureSEC source: 0000740260-25-000181 · wk-form4_1748034023.xml · nonDerivative · entry 3 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,364 F3 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. F4 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $64.06 to $64.95, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:00 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionCommon Stock | 33,592 | $53.79 | $1,806,913.68 |
DisclosureSEC source: 0000740260-25-000181 · wk-form4_1748034023.xml · nonDerivative · entry 2 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:00 UTC |
Probst Robert FEVP and CFO
|
SaleCommon Stock | 36,000 | $64.62 | $2,326,190.40 |
DisclosureSEC source: 0000740260-25-000181 · wk-form4_1748034023.xml · nonDerivative · entry 1 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,364 F1 · shares: Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $64.285 to $64.95, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 14, 2025 Filed May 15, 2025 20:54 UTC |
RAKOWICH WALTER CDirector
|
SaleCommon Stock | 1,459 | $63.76 | $93,025.69 |
DisclosureSEC source: 0000740260-25-000176 · wk-form4_1747342448.xml · nonDerivative · entry 2 RAKOWICH WALTER C · CIK 0001202432 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,454 F3 · shares: Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2024. F4 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $63.49 to $64.00, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:54 UTC |
Smith Maurice SDirector
|
GrantCommon Stock | 2,882 | $64.18 | $184,966.76 |
DisclosureSEC source: 0000740260-25-000179 · wk-form4_1747342466.xml · nonDerivative · entry 1 Smith Maurice S · CIK 0001841752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,080.443 F1 · shares: Restricted stock units granted by Issuer pursuant to the Ventas, Inc. 2022 Incentive Plan. The restricted stock units vest on the earlier of the one-year anniversary of the grant date or the date of Issuer's 2026 Annual Meeting of Stockholders. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:54 UTC |
Roy SumitDirector
|
GrantCommon Stock | 2,882 | $64.18 | $184,966.76 |
DisclosureSEC source: 0000740260-25-000178 · wk-form4_1747342459.xml · nonDerivative · entry 1 Roy Sumit · CIK 0001529329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,145.209 F1 · shares: Restricted stock units granted by Issuer pursuant to the Ventas, Inc. 2022 Incentive Plan. The restricted stock units vest on the earlier of the one-year anniversary of the grant date or the date of Issuer's 2026 Annual Meeting of Stockholders. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.